TickerFacts.

Company research / STE

Steris PLC (STE)

Build a valuation ↗↓ Download CSV

SEC name STERIS plc · CIK 0001757898 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, Steris PLC reported revenue of $5.94B. Revenue grew 8.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $6.04B.

Key ratios (year ended 2026-03-31)

44.2%
Gross margin
18.6%
Operating margin
13.2%
Net margin
10.9%
Return on year-end equity
8.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Headquarters locality: Ireland / Mentor · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$6.04B$5.94B$5.46B$5.14B$4.54B$4.22B$3.11B$3.03B$2.78B$2.62B$2.61B
Cost of Revenuen/a$3.31B$3.06B$2.92B$2.56B$2.34B$1.76B$1.71B$1.61Bn/an/a
Gross Profit$2.68B$2.63B$2.40B$2.22B$1.98B$1.88B$1.34B$1.32B$1.17B$1.09B$1.03B
R&D Expense$115.10M$112.90M$107.60M$103.70M$98.48M$86.66M$66.33M$65.55M$63.04M$60.78M$59.40M
Operating Income$1.14B$1.10B$866.60M$836.10M$791.10M$477.81M$548.37M$537.05M$411.02M$399.88M$226.21M
Depreciation & Amortization$490.90M$486.50M$476.20M$565.20M$552.90M$553.10M$219.24M$197.24M$225.92M$178.33M$188.14M
EBITDA$1.63B$1.59B$1.34B$1.40B$1.34B$1.03B$767.61M$734.28M$636.95M$578.22M$414.35M
Net Income$805.00M$782.30M$614.60M$378.20M$107.03M$243.89M$397.40M$407.66M$303.72M$290.92M$109.97M
EPS (Diluted)n/a$7.93$6.20$3.81$1.07$2.48$4.63$4.76$3.55$3.39$1.28
Total Assets$10.74B$10.74B$10.15B$11.06B$10.82B$11.42B$6.57B$5.44B$5.07B$5.20Bn/a
Total Liabilities$3.51B$3.54B$3.53B$4.75B$4.73B$4.88B$2.68B$2.02B$1.89B$1.98Bn/a
Long-Term Debt$1.65B$1.81B$1.92B$3.12B$3.02B$2.95B$1.65B$1.15B$1.18B$1.32Bn/a
Shareholders' Equity$7.22B$7.20B$6.62B$6.32B$6.09B$6.54B$3.89B$3.42B$3.20B$3.22B$2.81B
Cash & Equivalents$482.30Mn/an/an/an/an/a$220.53M$319.58M$220.63M$201.53M$282.92M
Operating Cash Flow$1.29B$1.34B$1.15B$973.30M$756.95M$684.81M$689.64M$590.56M$539.50M$457.63M$424.09M
Capital Expenditures$362.90M$369.00M$370.10M$360.30M$361.97M$287.56M$239.26M$214.52M$189.72M$165.46M$172.90M
Free Cash Flow$925.60M$972.40M$778.00M$613.00M$394.98M$397.25M$450.38M$376.04M$349.79M$292.18M$251.19M
Share Repurchases$340.40M$235.50M$211.30M$11.80M$308.56M$55.78M$14.65M$51.24M$81.49M$65.48M$97.51M
Dividends Paid$247.00M$241.80M$219.90M$200.60M$183.50M$163.17M$133.84M$123.03M$112.50M$102.93M$93.19M
Shares Outstanding97.50M97.80M98.30M98.88M98.63M100.07M85.35M84.92M84.52M84.75Mn/a
Dividends Per Sharen/a$2.46$2.23$2.03$1.84$1.69$1.57$1.45$1.33$1.21$1.09
Weighted Average Diluted Sharesn/a98.70M99.10M99.40M100.25M98.33M85.90M85.64M85.47M85.71M86.09M
EPS (Basic)n/a$7.97$6.24$3.83$1.07$2.50$4.66$4.81$3.59$3.42$1.29

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView